Squamous cell carcinoma of the cervix uteri: Molecular abnormalities of p53 and rb genes;Carcinoma epidermoide de cuello uterino: Anormalidades moleculares de los genes p53 y rb

Revista Medica de Chile

Volumn 124, Issue 5, 1996, Pages 553-560

  Wistuba O, Iván ^a,b   Capurro V, Italo ^a  

^a UNIVERSIDAD DE LA FRONTERA   (Chile)

^b Unidad de Anatomía Patológica   (Chile)

Author keywords

Carcinoma; Cervix neoplasms; Cervix uteri; Genes; Heterozygote; LOH, p53 gene, rb gene, p53 protein; Molecular biology

Indexed keywords

DNA;

ARTICLE; AUTORADIOGRAPHY; FEMALE; GENE EXPRESSION; GENETICS; HETEROZYGOTE; HUMAN; IMMUNOHISTOCHEMISTRY; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; POINT MUTATION; POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE; UTERINE CERVIX TUMOR;

AUTORADIOGRAPHY; BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; DNA, NEOPLASM; FEMALE; GENE EXPRESSION; GENES, P53; GENES, RETINOBLASTOMA; HETEROZYGOTE; HUMANS; IMMUNOHISTOCHEMISTRY; MOLECULAR SEQUENCE DATA; POINT MUTATION; POLYMERASE CHAIN REACTION; UTERINE CERVICAL NEOPLASMS;

EID: 0030133093     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. LEVINE A. The tumor suppressor genes. Annu Rev Biochem 1993; 62: 623-51.
2. MARSHALL C. Tumor suppressor genes. Cell 1991; 121: 313-26.
3. KNUDSON A. The ninth Gordon Hamilton-Fairley memorial lecture. Hereditary cancers: clues to mechanisms of carcinogenesis. Br J Cancer 1989; 59: 661-66.
4. HELLAND A, HOLM R, KRISTENSEN G ET AL. Genetic alterations of the TP53 gene, p53 protein expression and HPV infection in primary cervical carcinomas. J Pathol 1993; 171: 105-14.
5. KAELBLING M, BURK R, ATKIN N ET AL. Loss of heterozygosity on chromosome 17p and mutant p53 in HPV-negative cervical carcinomas. Lancet 1992; 340: 140-42.
6. PAQUETTE R, LEE Y, WILCZYNSKI S ET AL. Mutations of p53 and human papillomavirus infection in cervical carcinoma. Cancer 1993; 72: 1272-80.
7. MIWA K, MIYAMOTO S, KATO H ET AL. The role of p53 inactivation in human cervical cell carcinoma development. Br J Cancer 1995; 71: 219-26.
8. SCHNEIDER J, RUBIO M, RODRIGUEZ-ESCUDERO F ET AL. Identification of p53 mutations by means of single strand conformation polymorphism analysis in gynaecological tumours: comparison with the results of immunohistochemistry. Eur J Cancer 1994; 30A: 504-08.
9. SCHEFFNER M, MUNGER K, BYRNE J, HOWLEY P. The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc Natl Acad Sci (USA) 1991; 88: 5523-27.
10. CHOO K, CHONG K. Absence of mutation in the p53 and the retinoblastoma susceptibility genes in primary cervical carcinomas. Virology 1993; 193: 1042-104.
11. PAO C, KAO S, CHEN J ET AL. State of mutational alterations of p53 and retinoblastoma susceptibility genes in human papillomavirus-negative small cell cervical carcinomas. J Surg Oncol 1994; 57: 87-93.
12. PARK D, WILCZYNSKI S, PAQUETTE R ET AL. p53 mutations in HPV-negative cervical carcinoma. Oncogene 1994; 9: 205-10.
13. CROOK T, WREDE D, VOUSDEN K. p53 point mutation in HPV human cervical carcinoma cell lines. Oncogene 1991; 6: 873-75.
14. KURIHARA M, AOKI K, HISAMICHI S. In: Cancer moratality statistics in the world 1950-1985. Nagoya, Japan: The University of Nagoya Press. 1989; 120.
15. HUNG J, KISHIMOTO Y, SUGIO K ET AL. Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma. JAMA 1995; 273: 558-63.
16. JONES M, NAKAMURA Y. Detection of loss of heterozygosity at the human TP53 locus using a dinucleotide repeat polymorphism. Genes Chromosom Cancer 1992; 5: 89-90.
17. TOGUCHIDA J, MCGEE T, PATERSON J ET AL. Complete genomic sequence of the human retinoblastoma susceptibility gene. Genomics 1993; 17: 535-43.
18. KESSIS T, SIEBOS R, HAN S ET AL. p53 gene mutations and MDM2 amplification are uncommon in primary carcinomas of the uterine cervix. Am J Pathol 1993; 143: 1398-1405.
19. BUSBY-EARLE R, STEEL C, WILLIAMS A ET AL. p53 mutations in cervical carcinogenesis. Low frequency and lack of correlation with human papillomavirus status. Br J Cancer 1994; 69: 732-37.
20. CROOK T, WREDE D, TIDY J ET AL. Clonal p53 mutations in primary cervical cancer: association with human papillomavirus negative tumours. Lancet 1992; 339: 1070-73.
21. LEE J. Loss of heterozygosity on the short arm of chromosome 17 in uterine cervical carcinomas. Cancer Genet Cytogenet 1995; 79: 74-8.
22. KINOSHITA M, SHIN S, HIRAO T, AONO T. A quantitative approach to the loss of heterozygosity in p53 allele on detection of human cervical cancer using a BioImaging Analyzer. Asia Oceania. J Obstet Gynaecol 1994; 20; 87-92.
23. FUJITA M, INOUE M, TANIZAWA OET AL. Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection. Cancer Res 1992; 52: 5323-28.
24. AGUILAR F, HARRIS C, SUN M ET AL. Geographic variation of p53 mutational profile in nonmalignant human liver. Science 1994; 264: 1317-19.
25. KENNEDY S, MACGEOGH C, JAFFE R, SPURR N. Overexpression of the oncoprotein p53 in primary hepatic tumors of childhood does not correlate with mutations. Hum Pathol 1994; 25: 438-42.
26. HALL V, LANE D. p53 in tumor pathology: can we trust immunohistochemistry? Revisted J Pathol 1994; 172: 1-4.
27. WAGATA T, SHIBAGAKI I, IMAMURA M ET AL. Loss of 17p, mutation of the p53 gene, and overexpression of p53 protein in esophageal squamous cell carcinomas. Cancer Res 1993; 53: 846-50.
28. CORDON-CARDO C, DALBAGNI G, SAEZ G ET AL. p53 mutations in human bladder cancer: genotypic versus phenotypic patterns. In J Cancer 1994; 56: 347-53.
29. OKA K, NAKANO T, ARAI T. p53 CM1 expression is not associated with prognosis in uterine cervical carcinoma. Cancer 1993; 72: 160-64.
30. HOLM R, SKOMEBAL H, HELLAND A ET AL. Immunohistochemical analysis of p53 protein overexpression in normal, premalignant, and malignant tissues of the cervix uteri. J Pathol 1993; 169: 21-6.
31. GITSCH G, KAINZ C, JOURA E, BREITENECKER G. Mutant p53 product in patients with stage III cervical cancer. Anticancer Res 1992; 12: 2241-42.
32. CARDILLO M, STAMP G, PIGNATELLI M, LALANI E. Immunohistochemical analysis of p53 oncoprotein and proliferating cell nuclear antigen (PCNA) in the cervix uteri. Eur J Gynaecol Oncol 1993; 14: 484-90.
33. MCKEE P, HOBBS C, HALL P. Antigen retrieval by microwave irradiation lowers immunohistological detection tresholds. Histopathology 1993; 23: 377-79.
34. WISTUBA I, SUGIO K, HUNG J ET AL. Allele specific-mutations involved in the pathogenesis of endemic gallbladder carcinoma in Chile. Cancer Res 1995; 55: 2511-15.
35. ZHUANG Z, MERINO M, CUAQUI R ET AL. Identical allelic loss on chromosome 11q13 in microdissected in situ and invasive human breast cancer. Cancer Res 1995; 55: 467-71.